Gate Bioscience raises $65 million in an oversubscribed Series B financing led by Forbion to advance its oral molecular gate medicines into the clinic.
Amount Raised
$65 Million
Round Type
Series B
BrisbaneBiotechnologyHealth CareInvestors
Description
Gate Bioscience, a biotechnology company, announced the close of a $65 million oversubscribed Series B financing on November 13, 2025. The funding, led by Forbion and joined by Eli Lilly and other investors, aims to support the clinical development of its small molecule therapies. With a total capital raised reaching $135 million, this financing will help advance differentiated molecular gate programs targeting inflammatory and neurological diseases.
Quick answer
Gate Bioscience raised $65 Million in a Series B round, dated November 13, 2025. Investors: Eli Lilly And Company, Versant Ventures, Andreessen Horowitz, GV, ARCH Venture Partners and Forbion. Gate Bioscience is based in Brisbane, California, United States.
- How much did Gate Bioscience raise?
- Gate Bioscience raised $65 Million in a Series B round on November 13, 2025.
- Who invested in Gate Bioscience?
- Eli Lilly And Company, Versant Ventures, Andreessen Horowitz, GV, ARCH Venture Partners and Forbion are named as investors in this round.
- What does Gate Bioscience do?
- Gate Bioscience is a preclinical biotechnology company creating a new class of medicines called Molecular Gates.
- Where is Gate Bioscience based and how big is it?
- Gate Bioscience is based in Brisbane, California, United States. Fundz records about 42 employees.
- Who are the decision-makers at Gate Bioscience?
- Fundz holds 2 contacts at Gate Bioscience, including the Co-founder and CTO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Gate Bioscience that raised within 45 days of this round, from Fundz verified event records.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- Initiate raised an undisclosed amount (Private Equity) on December 23, 2025.
- FONAR raised $41M on December 23, 2025.
- Vyriad raised $25M (Series B) on December 23, 2025.
- Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
- FONAR raised $10M on December 23, 2025.
Who to call at Gate Bioscience, and when
A new round usually means Gate Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Gate Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gate Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gate Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gate Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGate Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.